Cristina Garufi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Evolution of therapy for autoimmune diseases in pregnancy: a retrospective study from 2000 to 2023.

Evolution of therapy for autoimmune diseases in pregnancy: a retrospective study from 2000 to 2023.

Journal: Frontiers in medicine

Published: September 30, 2025

Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus.

Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus.

Journal: Clinical and experimental rheumatology

Published: September 23, 2025

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.

Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.

Journal: ESMO open

Published: September 07, 2025

Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal study.

Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal study.

Journal: Clinical and experimental medicine

Published: January 30, 2025

Wnt signaling as a translational target in rheumatoid and psoriatic arthritis.

Wnt signaling as a translational target in rheumatoid and psoriatic arthritis.

Journal: Journal of translational medicine

Published: November 12, 2024

Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients: Results from a cross-sectional analysis.

Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients: Results from a cross-sectional analysis.

Journal: Lupus

Published: November 11, 2024

Rapid response to anifrolumab in lupus related joint involvement as assessed by ultrasonography: A case series study.

Rapid response to anifrolumab in lupus related joint involvement as assessed by ultrasonography: A case series study.

Journal: Joint bone spine

Published: October 14, 2024

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.

Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.

Journal: ESMO open

Published: September 26, 2024

Hepatitis E Virus Infection in Patients with Systemic and Cutaneous Lupus Erythematosus.

Hepatitis E Virus Infection in Patients with Systemic and Cutaneous Lupus Erythematosus.

Journal: International journal of molecular sciences

Published: August 28, 2024

Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot study.

Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot study.

Journal: Frontiers in immunology

Published: August 02, 2024

Antibody profiles in the mosaic of 'seronegative' APS syndrome.

Antibody profiles in the mosaic of 'seronegative' APS syndrome.

Journal: Clinical and experimental immunology

Published: May 24, 2024

Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus.

Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus.

Journal: Journal of the peripheral nervous system : JPNS

Published: April 29, 2024

Showing 1-12 of 51

Last Updated: 09/26/2026